The MONALEESA-3 study in HR+/HER2- advanced breast cancer

The MONALEESA-3 study in HR+/HER2- advanced breast cancer

User Photo
obr

2 years
161 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Douglas W. Blayney, MD, explains the significant improvement in PFS in the fulvestrant + ribociclib arm of the MONALEESA-3 study in HR+/HER2- advanced breast cancer

 

 

 

 

advanced breast cancer, HR+/HER2, MONALEESA-3 study, fulvestrant + ribociclib, significant improvement in PFS

Up Next Autoplay
>